Search

Search Constraints

You searched for: Author/Creator Santacruz, Anna

Search Results

1. Characterization of amyloid‐related imaging abnormality in the DIAN‐TU‐001 trial. (31st December 2021)

2. F4‐03‐02: The Dominantly Inherited Alzheimer Network Trials Unit. (1st July 2016)

3. FTS‐03‐03: THE DIAN‐TU. (1st July 2014)

4. Gantenerumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)

5. O1‐02‐03: DIAN‐TU ADAPTIVE PREVENTION TRIAL LAUNCH AND BASELINE DATA. (1st July 2006)

6. Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)

7. Solanezumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)

8. The design of Dominantly Inherited Alzheimer Disease Trial of the anti‐tau antibody, E‐2814, on the DIAN‐TU Tau Next Generation Platform. (31st December 2021)

9. The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model. Issue 1 (29th August 2016)